{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OPP-2005-0128-0157", "EPA", "EPA-HQ-OPP-2005-0128", "June 18, 2008. RESPONSE TO PUBLIC COMMENTS.  The Health Effects Division\u2019s Response to Comments on EPA\u2019s Phase 5 Reregistration Eligibility Decision Document for Dazomet (OPP Docket# OPP-2005-0128).", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-07-16T04:00:00Z", 2008, 7, null, null, "2008-07-16T13:36:28Z", null, 0, 0, "0900006480651b9f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OPP-2005-0128-0157"], "units": {}, "query_ms": 0.49215182662010193, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}